Yazar "Vural, Filiz" için listeleme
-
Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey
Turgut, Mehmet; Soyer, Nur; Ali, Rıdvan; Haznedaroğlu, İbrahim; Yılmaz, Fergun; İlhan, Gül; Cömert, Melda; Aslaner, Müzeyyen; İnce, İdris; Yavaşoğlu, İrfan; Özdemirkıran, Füsun; Özet, Gülsüm; Vural, Filiz; Şahin, Fahri; Töbü, Mahmut; Onmuş, İsabel Raika Durusoy; Saydam, Güray (TÜBİTAK, 2021)The aim of this study is to assess the efficacy and safety of ruxolitinib in patients with myelofibrosis. Materials and methods: From 15 centers, 176 patients (53.4% male, 46.6% female) were retrospectively evaluated. ... -
Ibrutinib: From Molecule to Medicine
Ayyildiz, Orhan; Demirkan, Fatih; Goker, Hakan; Haznedaroglu, Ibrahim C.; Ilhan, Osman; Kaynar, Leyla G.; Vural, Filiz (Akad Doktorlar Yayinevi, 2014)Bruton's tyrosine kinase (BTK) inhibitor Ibrutinib (PCI-32765) is a novel targeted-therapeutic agent modulating BCR, which serves as a covalent irreversible inhibitor of BTK. Ibrutinib significantly alters the composition ...
